Authors' response to "Venous Thromboembolism Risk Models in Hospitalized Medical Patients: The Time for Implementation, Not Never-Ending Development"

Neil A Zakai^{1

2

3}, Katherine S Wilkinson², Andrew D Sparks⁴, Mansour Gergi^{1

3}, Allen B Repp^{1

3}, Hanny Al-Samkari⁵, Ryan Thomas^{1

3}, Nicholas S Roetker⁶

Affiliations

¹ Department of Medicine, Larner College of Medicine at the University of Vermont, Burlington, Vermont, USA.
² Department of Pathology and Laboratory Medicine, Larner College of Medicine at the University of Vermont, Burlington, Vermont, USA.
³ University of Vermont Medical Center, Burlington, Vermont, USA.
⁴ Department of Medical Biostatistics, Biomedical Statistics Research Core, Larner College of Medicine at the University of Vermont, Burlington, Vermont, USA.
⁵ Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
⁶ Chronic Disease Research Group, Hennepin Healthcare Research Institute, Minneapolis, Minnesota, USA.

Neil A Zakai et al. Res Pract Thromb Haemost. 2024.

. 2024 Jun 21;8(4):102483.

doi: 10.1016/j.rpth.2024.102483. eCollection 2024 May.

Neil A Zakai^{1

2

3}, Katherine S Wilkinson², Andrew D Sparks⁴, Mansour Gergi^{1

3}, Allen B Repp^{1

3}, Hanny Al-Samkari⁵, Ryan Thomas^{1

3}, Nicholas S Roetker⁶

¹ Department of Medicine, Larner College of Medicine at the University of Vermont, Burlington, Vermont, USA.
² Department of Pathology and Laboratory Medicine, Larner College of Medicine at the University of Vermont, Burlington, Vermont, USA.
³ University of Vermont Medical Center, Burlington, Vermont, USA.
⁴ Department of Medical Biostatistics, Biomedical Statistics Research Core, Larner College of Medicine at the University of Vermont, Burlington, Vermont, USA.
⁵ Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
⁶ Chronic Disease Research Group, Hennepin Healthcare Research Institute, Minneapolis, Minnesota, USA.

No abstract available

Keywords: adult; bleeding; inpatients; risk assessment; venous thrombosis.

References

1. Spyropoulos A.C., Ramacciotti E. Venous thromboembolism risk models in hospitalized medical patients: the time for implementation, not never-ending development. Res Pract Thromb Haemost. 2024 doi: 10.1016/j.rpth.2024.102473. in press. - DOI - PMC - PubMed
1. Wilkinson K.S., Sparks A.D., Gergi M., Repp A.B., Al-Samkari H., Thomas R., et al. Validation of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) risk scores for venous thromboembolism and bleeding in an independent population. Res Pract Thromb Haemost. 2024;8 doi: 10.1016/j.rpth.2024.102441. - DOI - PMC - PubMed
1. Spyropoulos A.C., Anderson F.A. J.r., FitzGerald G., Decousus H., Pini M., Chong B.H., et al. Predictive and associative models to identify hospitalized medical patients at risk for VTE. Chest. 2011;140:706–714. - PubMed
1. Zakai N.A., Wilkinson K., Sparks A.D., Packer R.T., Koh I., Roetker N.S., et al. Development and validation of a risk model for hospital-acquired venous thrombosis: the Medical Inpatients Thrombosis and Hemostasis study. J Thromb Haemost. 2024;22:503–515. - PMC - PubMed
1. Nicolaides A.N., Fareed J., Spyropoulos A.C., Kakkar R.H.L., Antignani P.L., Avgerinos E., et al. Prevention and management of venous thromboembolism. International Consensus Statement. Guidelines according to scientific evidence. Int Angiol. 2024;43:1–222. - PubMed